Andrew Siderowf

Dr. Andrew Siderowf, Hertig Stern Professor of Neurology at the University of Pennsylvania, dives into the evolving landscape of Parkinson's disease research. He discusses the prominence of alpha-synuclein biomarkers and their implications for diagnosis and treatment. The conversation highlights innovative methods like skin-based assays and imaging biomarkers. Siderowf also explores the future of treatment, including the impact of artificial intelligence on therapeutic strategies and the complexity of the disease beyond synuclein pathology.